Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Avalyn Pharma Inc.
Avalyn Announces First Patient Dosed in AURA Phase 2 Clinical Trial Evaluating AP02, Inhaled Nintedanib, for the Treatment of Idiopathic Pulmonary Fibrosis
May 3, 2026
Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors
April 30, 2026
←
Previous Page
1
2